AssetBridge BioAdvisory — Cross-border healthcare advisory firm connecting China and global markets in biopharma licensing, NewCo formation, and strategic transactions.

What We Do
• 🔄 Licensing (Buy/Sell): Source, assess, and negotiate biopharma assets
• 🧬 NewCo Formation: Structure JVs or spin-outs to accelerate growth and financing
• 💼 Fundraising Advisory: Connect innovators with strategic and financial investors
• 🌍 Market Entry: China & ex-China go-to-market strategies

Why Partner with Us
• 📈 Proven Experience: Team’s combined $1.2B+ in successful transactions
• 👥 Expert Team: Former leaders from Sanofi, Boehringer Ingelheim, Novartis, AstraZeneca
• 🌐 Global Reach: Boston · Paris · Shanghai · Basel
• 🧠 Intelligence Edge: AI-enabled deal platform + CRO network

Our Commitment
• Beyond advice — into the deal
• Bridging molecules, markets, and decision-makers

AssetBridge BioAdvisory

Org chart

Teams

Offices